Table of Contents

Figures and Tables
Executive Summary
Key Findings and Implications
Gene Silencing Dashboard
Gene Silencing Market Opportunity Matrix
Survey Methodology
Survey Invitation Text
Respondent Demographics
Frequency of Performance of Molecular Biology Techniques
Frequency of Performance of Gene Silencing Techniques
Reaction Throughput and Market Growth Rates
Respondent’s Stated Price Per Reaction
Total Market Size, Market Segment Sizes and Total Market Growth Rate
Market Shares by Segment (Share of Mention)
Customer Satisfaction And Interest In Switching Suppliers
Product Features That Influence Purchasing Decisions
Primary Downstream Applications
Desired Changes to Gene Silencing Products
Survey Questionnaire

Figures and Tables
Figure 1: Respondent’s Place of Employment
Figure 2: Respondent’s Country/Region
Figure 3: Respondent’s Job Title
Figure 4: Respondent’s Areas of Expertise/Specialization
Figure 5: Number of Employees in Respondent’s Laboratories
Figure 6: Percentage of Respondents Performing Various Techniques at Least
                 a Few Times per Year
Figure 7: Percentage of Respondents Performing RNAi/siRNA Experiments
Figure 8: Percentage of Respondents Performing Various Gene Silencing
                 Techniques at Least a Few Times per Year
Figure 9: Percentage of Respondents That Perform RNAi Screens Using
                 siRNA Libraries
Figure 10: Percentage of Respondents That Induce siRNAs in vivo from a
                   Plasmid or Other Vector in Cells
Figure 11: Percentage of Respondents That Deliver Synthetic siRNAs into Cells
Figure 12: Percentage of Respondents That Digest Long dsRNA in vivo using
                   Dicer or Other Enzymes
Figure 13: Percentage of Respondents That Express siRNA in vitro for
                   Delivery into Cells
Figure 14: Percentage of Respondents That Use PCR Mediated siRNA
                   Expression Cassettes to Generate siRNAs
Figure 15: Percentage of Respondents That Deliver siRNAs into Cells
                   by Transfection
Figure 16: Percentage of Respondents That Deliver siRNAs into Cells
                   by Electroporation
Figure 17: Percentage of Respondents That Deliver siRNAs into Cells
                   by Viral Infection
Figure 18: Percentage of Respondents That Use a Reporter Systems
                   to Track Gene Knockdown
Figure 19: Respondent's Primary Supplier for RNAi Screens Using
                   siRNA Libraries
Figure 20: Respondent's Primary Supplier for Products to Induce siRNAs
                   in vivo from a Plasmid or Other Vector in Cells
Figure 21: Respondent's Primary Supplier for Products to Deliver
                   Synthetic siRNAs into Cells
Figure 22: Respondent's Primary Supplier for Products to Digest Long
                   dsRNA in vivo using Dicer or Other Enzymes
Figure 23: Respondent's Primary Supplier for Products to Express siRNA
                   in vitro for Delivery into Cells
Figure 24: Respondent's Primary Supplier for PCR Mediated siRNA
                   Expression Cassettes to Generate siRNAs
Figure 25: Respondent's Primary Supplier for Products to Deliver
                   siRNAs into Cells by Transfection
Figure 26: Respondent's Primary Supplier for Products to Deliver
                   siRNAs into Cells by Electroporation
Figure 27: Respondent's Primary Supplier for Products to Deliver
                   siRNAs into Cells by Viral Infection
Figure 28: Respondent's Primary Supplier of Reporter Systems to Track
                   Gene Knockdown
Figure 29: Percentage of Respondents That Have Switched Suppliers
                   in the Last Six Months
Figure 30: Most Important Features of Products for Gene Silencing Experiments
Figure 31: Respondent's Primary Downstream Application for RNAi
                   Screens Using siRNA Libraries
Figure 32: Respondent's Primary Downstream Application for Products to
                   Induce siRNAs in vivo from a Plasmid or Other Vector in Cells
Figure 33: Respondent's Primary Downstream Application for Products to
                   Deliver Synthetic siRNAs into Cells
Figure 34: Respondent's Primary Downstream Application for Products to
                   Digest Long dsRNA in vivo using Dicer or Other Enzymes
Figure 35: Respondent's Primary Downstream Application for Products to
                   Express siRNA in vitro for Delivery into Cells
Figure 36: Respondent's Primary Downstream Application for PCR Mediated
                   siRNA Expression Cassettes to Generate siRNAs
Figure 37: Respondent's Primary Downstream Application for Products to
                   Deliver siRNAs into Cells by Transfection
Figure 38: Respondent's Primary Downstream Application for Products to
                   Deliver siRNAs into Cells by Electroporation
Figure 39: Respondent's Primary Downstream Application for Products to
                   Deliver siRNAs into Cells by Viral Infection
Figure 40: Respondent's Primary Downstream Application for Reporter
                   Systems to Track Gene Knockdown

Table 1: Frequency of Performance of Various Techniques
Table 2: Frequency of Co-Performance of Various Molecular Biology Techniques
Table 3: Frequency of Performance of Gene Silencing Methods
Table 4: Frequency of Co-Performance of Life Science Techniques with
               Gene Silencing Methods
Table 5: Frequency of Co-Performance of Gene Silencing Methods with
                Life Science Techniques
Table 6: Median and Average Monthly Throughput for Gene Silencing Products
Table 7: Percentage of Respondents Performing Various Numbers of Gene
                Silencing Reactions Per Month
Table 8: Projected Growth in the Performance of Various Gene
                Silencing Techniques
Table 9: Median and Average Price Per Prep for Gene Silencing Products
Table 10: Market Share Leaders for Gene Silencing Products
Table 11: Percentage of Respondents Satisfied with Various Gene Silencing
                  Products and Reasons for Dissatisfaction
Table 12: Respondents Primary Application After Various Gene
                  Silencing Methods